Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
22nd Century Group (NASDAQ: XXII) pioneers plant-based solutions for tobacco harm reduction through advanced biotechnology. This news hub provides investors and stakeholders with essential updates on regulatory milestones, product innovations, and operational developments central to the company's mission of reducing nicotine addiction.
Access authoritative coverage of FDA communications, VLN product advancements, and manufacturing capacity updates. Our curated collection includes earnings reports, patent filings, and scientific research collaborations that demonstrate 22nd Century's leadership in developing reduced-nicotine tobacco products.
Key updates feature the company's Modified Risk Tobacco Product authorization, progress in international market expansion, and innovations in nicotine biosynthesis control. Regular updates ensure informed tracking of this biotechnology firm's unique position at the intersection of public health and commercial tobacco production.
Bookmark this page for streamlined access to verified corporate announcements and analysis-free reporting on 22nd Century's progress in redefining tobacco consumption through science-driven solutions.
22nd Century Group (Nasdaq: XXII) announced significant progress in state authorizations for its tobacco product portfolio. The company has secured approval to sell its VLN® reduced nicotine content cigarettes in up to 41 states, along with expanded authorizations for partner brands and conventional products.
The company's flagship VLN® products contain 95% less nicotine than conventional cigarettes and are the only combustible cigarettes that comply with the FDA's proposed Low Nicotine Mandate. 22nd Century has secured partnerships with retailers representing over 2,000 outlets for implementation in the second half of 2025.
The expanded state authorizations cover multiple product lines including VLN® Gold and Green (41 states), VLN® Red (21 states), Smoker Friendly VLN® (20 states), Pinnacle® VLN® (20 states), and various conventional products across different states.
22nd Century Group (Nasdaq: XXII) is gaining traction with its VLN® reduced nicotine content cigarettes as multiple tobacco brands partner to expand product availability. The company's proprietary tobacco contains 95% less nicotine than conventional cigarettes, meeting the FDA's proposed standard of 0.7 mg nicotine per gram of tobacco.
The FDA's January 2025 proposed Tobacco Product Standard aims to reduce smoking-related harm by limiting nicotine content in cigarettes. VLN® products, averaging 0.5 mg per gram, are currently the only FDA-authorized combustible cigarettes meeting this standard. The FDA projects this initiative could prevent approximately 48 million youth and young adults from starting smoking by 2100.
New partnerships including Smoker Friendly VLN® and Pinnacle VLN® demonstrate growing industry adoption ahead of the standard's implementation, expected two years after final approval.
22nd Century Group (Nasdaq: XXII) provided an update on the Modified Risk Tobacco Product (MRTP) renewal process for its VLN® reduced nicotine content products. VLN® is the first and only FDA-authorized combustible cigarette containing 95% less nicotine than conventional cigarettes, with renewal due in December 2026.
The company's VLN® products, originally authorized in December 2021, have demonstrated through extensive clinical research their ability to reduce smoking rates, increase quit attempts, and lower nicotine consumption. The product line is expanding with more brands using VLN® tobacco, meeting FDA's proposed low nicotine mandate issued in January 2025.
22nd Century Group (Nasdaq: XXII) has announced "Operation 100," an initiative to develop a 100mm version of their VLN® reduced nicotine content cigarettes. The company plans to submit this new product for FDA approval in Q4 2025.
The 100mm format targets approximately half of the U.S. smoking market and will complement their existing FDA-authorized 84mm king size VLN® cigarettes. The product will be available under the VLN® brand and through partner brands like Smoker Friendly and Pinnacle.
Clinical studies have demonstrated that 22nd Century's proprietary reduced nicotine tobacco helps lower cigarette consumption, increases quit attempts, and reduces cigarette dependence without compensatory smoking behaviors.
22nd Century Group (Nasdaq: XXII) has expanded its Pinnacle brand partnership with a top-5 convenience store chain, launching four new products including two VLN® (low nicotine) cigarette variants and two moist snuff products. The products will be distributed across more than 1,700 stores in 27 states.
The new products include Pinnacle VLN® Gold cigarettes, Pinnacle Menthol VLN® cigarettes, and straight and wintergreen flavored moist snuff. Sales are expected to begin in late summer and early fall 2025, pending state approvals. The agreement also includes potential expansion to other retail and c-store chains.
22nd Century Group (NASDAQ: XXII), a tobacco products company focused on nicotine control solutions, has announced that CEO Larry Firestone will deliver a corporate update presentation at the Emerging Growth Conference on May 21, 2025, at 12:00 PM ET. The presentation will cover recent company developments and include a potential Q&A session.
Investors can submit questions in advance via email and register for the event through the provided webcast link. For those unable to attend live, an archived recording will be available on EmergingGrowth.com and the Emerging Growth YouTube Channel.
22nd Century Group (NASDAQ: XXII) has completed the sale of its Needle Rock Farms assets for net proceeds of approximately $770,000 after expenses. The assets were previously related to the company's hemp cannabis business, which was divested in December 2023. CEO Larry Firestone stated that the proceeds will strengthen the company's cash position and support their 2025 revenue growth strategies, including new VLN® and Partner VLN® launches. The company will report its Q1 2025 results on May 13, 2025.
22nd Century Group (NASDAQ: XXII) has announced an additional $1.0 million debt reduction to its senior lender, bringing its total debt principal to approximately $3.9 million. Year to date, the company has achieved a total debt reduction of about $3.8 million. CEO Larry Firestone highlighted that total debt obligations have decreased significantly from approximately $20 million in December 2023 when he joined the company. The tobacco products company aims to become debt-free to focus resources on growth opportunities in contract manufacturing, reduced nicotine content, and branded products. The company will report its Q1 2025 results on May 13, 2025.
22nd Century Group (NASDAQ: XXII), a tobacco products company focused on nicotine control solutions, has scheduled its Q1 2025 earnings announcement for May 13, 2025. The company will release its financial results via press release at 6:00 AM ET, followed by a webcast at 8:00 AM ET.
CEO Larry Firestone and CFO Dan Otto will lead the webcast, covering financial performance, recent developments, and outlining plans for 2025. Investors can access the webcast through the company's IR website at ir.xxiicentury.com/events, with registration recommended 10 minutes before start time.
FAQ
What is the current stock price of 22Nd Century (XXII)?
What is the market cap of 22Nd Century (XXII)?
